Cargando…
P957: CARFILZOMIB, LENALIDOMIDE, DEXAMETHASONE FOLLOWED BY A SECOND AUTO-HCT IS AN EFFECTIVE STRATEGY IN FIRST RELAPSE MULTIPLE MYELOMA: A STUDY OF THE CHRONIC MALIGNANCIES WORKING PARTY OF EBMT
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430523/ http://dx.doi.org/10.1097/01.HS9.0000846696.43332.f6 |
| _version_ | 1784779793934319616 |
|---|---|
| author | Tilmont, R. Yakoub-Agha, I. Eikema, D.-J. Zinger, N. Haenel, M. Schaap, N. Herrera Arroyo, C. Schuermans, C. Bethge, W. Engelhardt, M. Kuball, J. Michieli, M. Schub, N. Wilson, K. M. O. Bourhis, J. H. Mateos, M. V. Robin, N. Jost, E. Kröger, N. Moraleda, J. M. Sica, S. Hayden, P. J. Beksac, M. Schönland, S. Manier, S. |
| author_facet | Tilmont, R. Yakoub-Agha, I. Eikema, D.-J. Zinger, N. Haenel, M. Schaap, N. Herrera Arroyo, C. Schuermans, C. Bethge, W. Engelhardt, M. Kuball, J. Michieli, M. Schub, N. Wilson, K. M. O. Bourhis, J. H. Mateos, M. V. Robin, N. Jost, E. Kröger, N. Moraleda, J. M. Sica, S. Hayden, P. J. Beksac, M. Schönland, S. Manier, S. |
| author_sort | Tilmont, R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430523 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94305232022-08-31 P957: CARFILZOMIB, LENALIDOMIDE, DEXAMETHASONE FOLLOWED BY A SECOND AUTO-HCT IS AN EFFECTIVE STRATEGY IN FIRST RELAPSE MULTIPLE MYELOMA: A STUDY OF THE CHRONIC MALIGNANCIES WORKING PARTY OF EBMT Tilmont, R. Yakoub-Agha, I. Eikema, D.-J. Zinger, N. Haenel, M. Schaap, N. Herrera Arroyo, C. Schuermans, C. Bethge, W. Engelhardt, M. Kuball, J. Michieli, M. Schub, N. Wilson, K. M. O. Bourhis, J. H. Mateos, M. V. Robin, N. Jost, E. Kröger, N. Moraleda, J. M. Sica, S. Hayden, P. J. Beksac, M. Schönland, S. Manier, S. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430523/ http://dx.doi.org/10.1097/01.HS9.0000846696.43332.f6 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Tilmont, R. Yakoub-Agha, I. Eikema, D.-J. Zinger, N. Haenel, M. Schaap, N. Herrera Arroyo, C. Schuermans, C. Bethge, W. Engelhardt, M. Kuball, J. Michieli, M. Schub, N. Wilson, K. M. O. Bourhis, J. H. Mateos, M. V. Robin, N. Jost, E. Kröger, N. Moraleda, J. M. Sica, S. Hayden, P. J. Beksac, M. Schönland, S. Manier, S. P957: CARFILZOMIB, LENALIDOMIDE, DEXAMETHASONE FOLLOWED BY A SECOND AUTO-HCT IS AN EFFECTIVE STRATEGY IN FIRST RELAPSE MULTIPLE MYELOMA: A STUDY OF THE CHRONIC MALIGNANCIES WORKING PARTY OF EBMT |
| title | P957: CARFILZOMIB, LENALIDOMIDE, DEXAMETHASONE FOLLOWED BY A SECOND AUTO-HCT IS AN EFFECTIVE STRATEGY IN FIRST RELAPSE MULTIPLE MYELOMA: A STUDY OF THE CHRONIC MALIGNANCIES WORKING PARTY OF EBMT |
| title_full | P957: CARFILZOMIB, LENALIDOMIDE, DEXAMETHASONE FOLLOWED BY A SECOND AUTO-HCT IS AN EFFECTIVE STRATEGY IN FIRST RELAPSE MULTIPLE MYELOMA: A STUDY OF THE CHRONIC MALIGNANCIES WORKING PARTY OF EBMT |
| title_fullStr | P957: CARFILZOMIB, LENALIDOMIDE, DEXAMETHASONE FOLLOWED BY A SECOND AUTO-HCT IS AN EFFECTIVE STRATEGY IN FIRST RELAPSE MULTIPLE MYELOMA: A STUDY OF THE CHRONIC MALIGNANCIES WORKING PARTY OF EBMT |
| title_full_unstemmed | P957: CARFILZOMIB, LENALIDOMIDE, DEXAMETHASONE FOLLOWED BY A SECOND AUTO-HCT IS AN EFFECTIVE STRATEGY IN FIRST RELAPSE MULTIPLE MYELOMA: A STUDY OF THE CHRONIC MALIGNANCIES WORKING PARTY OF EBMT |
| title_short | P957: CARFILZOMIB, LENALIDOMIDE, DEXAMETHASONE FOLLOWED BY A SECOND AUTO-HCT IS AN EFFECTIVE STRATEGY IN FIRST RELAPSE MULTIPLE MYELOMA: A STUDY OF THE CHRONIC MALIGNANCIES WORKING PARTY OF EBMT |
| title_sort | p957: carfilzomib, lenalidomide, dexamethasone followed by a second auto-hct is an effective strategy in first relapse multiple myeloma: a study of the chronic malignancies working party of ebmt |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430523/ http://dx.doi.org/10.1097/01.HS9.0000846696.43332.f6 |
| work_keys_str_mv | AT tilmontr p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT yakoubaghai p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT eikemadj p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT zingern p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT haenelm p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT schaapn p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT herreraarroyoc p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT schuermansc p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT bethgew p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT engelhardtm p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT kuballj p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT michielim p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT schubn p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT wilsonkmo p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT bourhisjh p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT mateosmv p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT robinn p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT joste p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT krogern p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT moraledajm p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT sicas p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT haydenpj p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT beksacm p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT schonlands p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt AT maniers p957carfilzomiblenalidomidedexamethasonefollowedbyasecondautohctisaneffectivestrategyinfirstrelapsemultiplemyelomaastudyofthechronicmalignanciesworkingpartyofebmt |